IP Library › Assignment 046688/0661
Patent Assignment
Reel/Frame 046688/0661

Assignment of Assignor's Interest

Recorded: 2018-08-02 Pages: 83
Assignor
OREXIGEN THERAPEUTICS, INC.
Executed: 2018-07-13
Assignee
NALPROPION PHARMACEUTICALS, INC.
10 NORTH PARK PLACE, SUITE 201, MORRISTOWN, NEW JERSEY, 07960
Covered Properties (10)
Compositions for Affecting Weight Loss
Patent: 7,375,111 →
Application: 10/828,795 →
Publication: US 2004/0254208
Compositions for Affecting Weight Loss
Patent: 7,462,626 →
Application: 11/356,839 →
Publication: US 2006/0142290
Compositions and methods for increasing insulin sensitivity
Patent: 8,815,889 →
Application: 11/602,571 →
Publication: US 2007/0128298
Sustained Release Formulation of Naltrexone
Patent: 8,916,195 →
Application: 11/757,773 →
Publication: US 2007/0281021
Layered Pharmaceutical Formulations
Patent: 8,088,786 →
Application: 11/937,421 →
Publication: US 2008/0113026
Methods for Administering Weight Loss Medications
Patent: 8,722,085 →
Application: 12/838,364 →
Publication: US 2011/0059170
Methods of Providing Weight Loss Therapy in Patients with Major Depression
Patent: 9,248,123 →
Application: 12/987,909 →
Publication: US 2011/0172260
Layered Pharmaceutical Formulations
Patent: 8,318,788 →
Application: 13/330,395 →
Publication: US 2012/0093889
Methods for Administering Weight Loss Medications
Patent: 9,125,868 →
Application: 14/220,349 →
Publication: US 2014/0322318
Sustained Release Formulation of Naltrexone
Patent: 9,107,837 →
Application: 14/555,475 →
Publication: US 2015/0080424
Related Assignments (11)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 9, 2012
From: MCKINNEY, ANTHONY; TOLLEFSON, GARY; WEBER, ECKARD; SOLTERO, RICK
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 029121/0736 →
Assignment of Assignor's Interest Mar 18, 2014
From: MCKINNEY, ANTHONY; TOLLEFSON, GARY; WEBER, ECKARD; SOLTERO, RICK
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 032463/0479 →
Assignment of Assignor's Interest Jul 15, 2014
From: MCKINNEY, ANTHONY; TOLLEFSON, GARY; WEBER, ECKARD; SOLTERO, RICK
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 033312/0523 →
Assignment of Assignor's Interest Dec 18, 2015
From: DUNAYEVICH, EDUARDO; DEWITT (LEGAL REPRESENTATIVE OF GARY TOLLEFSON (DECEASED)), DAVID
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 037334/0490 →
Security Agreement Mar 21, 2016
From: OREXIGEN THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 038180/0021 →
Assignment of Assignor's Interest Mar 22, 2017
From: MCKINNEY, ANTHONY A.; TOLLEFSON, GARY D.; SOLTERO, RICHARD; DUNZO, THEA ELISE
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 041688/0895 →
Assignment of Assignor's Interest Mar 22, 2017
From: WEBER, ECKARD; COWLEY, MICHAEL ALEXANDER
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 041688/0847 →
Security Interest Aug 6, 2018
From: NALPROPION PHARMACEUTICALS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 047288/0321 →
Release of Security Interest Sep 27, 2019
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 050574/0106 →
Change of Name Oct 17, 2019
From: NALPROPION PHARMACEUTICALS, INC.
To: NALPROPION PHARMACEUTICALS LLC
Reel/Frame 050750/0497 →
Security Interest Dec 19, 2019
From: CURRAX PHARMACEUTICALS LLC; NALPROPION PHARMACEUTICALS LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 051377/0958 →